SRTS
Price
$4.92
Change
-$0.11 (-2.19%)
Updated
Jun 6 closing price
Capitalization
61.97M
54 days until earnings call
TWST
Price
$31.57
Change
+$1.24 (+4.09%)
Updated
Jun 6 closing price
Capitalization
1.98B
55 days until earnings call
Interact to see
Advertisement

SRTS vs TWST

Header iconSRTS vs TWST Comparison
Open Charts SRTS vs TWSTBanner chart's image
Sensus Healthcare
Price$4.92
Change-$0.11 (-2.19%)
Volume$43.54K
Capitalization61.97M
Twist Bioscience
Price$31.57
Change+$1.24 (+4.09%)
Volume$1.48M
Capitalization1.98B
SRTS vs TWST Comparison Chart
Loading...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRTS vs. TWST commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRTS is a Hold and TWST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (SRTS: $4.92 vs. TWST: $31.57)
Brand notoriety: SRTS and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SRTS: 41% vs. TWST: 112%
Market capitalization -- SRTS: $61.97M vs. TWST: $1.98B
SRTS [@Medical Specialties] is valued at $61.97M. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRTS’s FA Score shows that 1 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • SRTS’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, SRTS is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRTS’s TA Score shows that 6 TA indicator(s) are bullish while TWST’s TA Score has 5 bullish TA indicator(s).

  • SRTS’s TA Score: 6 bullish, 4 bearish.
  • TWST’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both SRTS and TWST are a good buy in the short-term.

Price Growth

SRTS (@Medical Specialties) experienced а +3.36% price change this week, while TWST (@Medical Specialties) price change was +7.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.46%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

SRTS is expected to report earnings on Jul 31, 2025.

TWST is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (+2.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.98B) has a higher market cap than SRTS($62M). SRTS YTD gains are higher at: -28.902 vs. TWST (-32.064). SRTS has higher annual earnings (EBITDA): 79K vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. SRTS (23.1M). SRTS has less debt than TWST: SRTS (783K) vs TWST (91.9M). TWST has higher revenues than SRTS: TWST (262M) vs SRTS (24.4M).
SRTSTWSTSRTS / TWST
Capitalization62M1.98B3%
EBITDA79K-172.41M-0%
Gain YTD-28.902-32.06490%
P/E Ratio126.00N/A-
Revenue24.4M262M9%
Total Cash23.1M311M7%
Total Debt783K91.9M1%
FUNDAMENTALS RATINGS
SRTS vs TWST: Fundamental Ratings
SRTS
TWST
OUTLOOK RATING
1..100
758
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
5994
PRICE GROWTH RATING
1..100
5488
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (43) in the Biotechnology industry is in the same range as SRTS (72) in the Medical Specialties industry. This means that TWST’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (78) in the Medical Specialties industry is in the same range as TWST (100) in the Biotechnology industry. This means that SRTS’s stock grew similarly to TWST’s over the last 12 months.

SRTS's SMR Rating (59) in the Medical Specialties industry is somewhat better than the same rating for TWST (94) in the Biotechnology industry. This means that SRTS’s stock grew somewhat faster than TWST’s over the last 12 months.

SRTS's Price Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for TWST (88) in the Biotechnology industry. This means that SRTS’s stock grew somewhat faster than TWST’s over the last 12 months.

SRTS's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for TWST (100) in the Biotechnology industry. This means that SRTS’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRTSTWST
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNEFX65.130.41
+0.63%
American Funds New Economy F3
PBAKX15.450.07
+0.46%
BlackRock Tactical Opportunities K
JHCPX15.86N/A
N/A
JHFunds2 Capital Appreciation NAV
BIGUX30.74N/A
N/A
Baron International Growth R6
HJIGX14.80N/A
N/A
Hardman Johnston Intl Gr Fd Instl Shr

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
-2.19%
LUNG - SRTS
57%
Loosely correlated
+6.73%
VAPO - SRTS
35%
Loosely correlated
N/A
PLSE - SRTS
33%
Loosely correlated
+4.78%
TWST - SRTS
28%
Poorly correlated
+4.09%
BFLY - SRTS
28%
Poorly correlated
+5.53%
More

TWST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TWST has been loosely correlated with GH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TWST jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TWST
1D Price
Change %
TWST100%
+4.09%
GH - TWST
51%
Loosely correlated
-0.72%
A - TWST
50%
Loosely correlated
+1.63%
VCYT - TWST
50%
Loosely correlated
+1.78%
IQV - TWST
50%
Loosely correlated
+3.36%
ALGN - TWST
49%
Loosely correlated
+0.20%
More